Our results also demonstrated that increased expression of ARF4, BSG, and HSP90 was significantly associated with shorter overall survival time in cervical cancer patients (Figure 5), suggesting that these genes might act as oncogenes in cervical cancer, and serve as potential biomarkers for predicting the prognosis of cervical cancer patients. The gene discussed is HSP90AA1; the disease is cervical cancer.